Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU)

Sankar Surendran, Dena Matalon, Stephen K. Tyring, Peter L. Rady, Gopalrao V Velagaleti, Reuben Matalon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Phenylketonuria (PKU) is an inborn error of amino acid metabolism. Phenylalanine hydroxylase (PAH) mutations resulting reduced enzyme levels lead to accumulation of phenylalanine (Phe) in brain, if Phe diet is not restricted. Patients with PKU show neurophysiological abnormalities including demyelination and cognitive defect. How PAH defect causes events seen in PKU is not obvious. Therefore, expression analysis was performed in the brain of a mouse model for PKU. Microarray expression profile of the brain showed lower expression of myocilin (Myoc) in the PKU mouse. Reduced expression of Myoc was further confirmed by one-step real-time RT-PCR. Western blotting analysis of the brain using equal quantities of protein showed a thin band in PKU compared to a prominent band in the wild type brain. In addition, expression of genes associated with transcription was found to be altered in the PKU mouse brain as observed by microarray analysis. These data suggest that PAH defect alters other genes expression likely to contribute neurophysiological abnormalities seen in the mouse, if documented also in patients with PKU.

Original languageEnglish (US)
Pages (from-to)323-326
Number of pages4
JournalNeuroscience Letters
Volume382
Issue number3
DOIs
StatePublished - Jul 15 2005
Externally publishedYes

Fingerprint

Phenylketonurias
Brain
Phenylalanine Hydroxylase
Phenylalanine
Inborn Errors Amino Acid Metabolism
Gene Expression
trabecular meshwork-induced glucocorticoid response protein
Demyelinating Diseases
Microarray Analysis
Real-Time Polymerase Chain Reaction
Western Blotting
Diet
Mutation
Enzymes

Keywords

  • BTBR-PAH
  • Myoc
  • Myocilin
  • Phenylalanine hydroxylase
  • Phenylketonuria (PKU)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU). / Surendran, Sankar; Matalon, Dena; Tyring, Stephen K.; Rady, Peter L.; Velagaleti, Gopalrao V; Matalon, Reuben.

In: Neuroscience Letters, Vol. 382, No. 3, 15.07.2005, p. 323-326.

Research output: Contribution to journalArticle

Surendran, Sankar ; Matalon, Dena ; Tyring, Stephen K. ; Rady, Peter L. ; Velagaleti, Gopalrao V ; Matalon, Reuben. / Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU). In: Neuroscience Letters. 2005 ; Vol. 382, No. 3. pp. 323-326.
@article{32c1a4c1cbed4247b03fabcf9c9b7195,
title = "Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU)",
abstract = "Phenylketonuria (PKU) is an inborn error of amino acid metabolism. Phenylalanine hydroxylase (PAH) mutations resulting reduced enzyme levels lead to accumulation of phenylalanine (Phe) in brain, if Phe diet is not restricted. Patients with PKU show neurophysiological abnormalities including demyelination and cognitive defect. How PAH defect causes events seen in PKU is not obvious. Therefore, expression analysis was performed in the brain of a mouse model for PKU. Microarray expression profile of the brain showed lower expression of myocilin (Myoc) in the PKU mouse. Reduced expression of Myoc was further confirmed by one-step real-time RT-PCR. Western blotting analysis of the brain using equal quantities of protein showed a thin band in PKU compared to a prominent band in the wild type brain. In addition, expression of genes associated with transcription was found to be altered in the PKU mouse brain as observed by microarray analysis. These data suggest that PAH defect alters other genes expression likely to contribute neurophysiological abnormalities seen in the mouse, if documented also in patients with PKU.",
keywords = "BTBR-PAH, Myoc, Myocilin, Phenylalanine hydroxylase, Phenylketonuria (PKU)",
author = "Sankar Surendran and Dena Matalon and Tyring, {Stephen K.} and Rady, {Peter L.} and Velagaleti, {Gopalrao V} and Reuben Matalon",
year = "2005",
month = "7",
day = "15",
doi = "10.1016/j.neulet.2005.03.030",
language = "English (US)",
volume = "382",
pages = "323--326",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Altered expression of myocilin in the brain of a mouse model for phenylketonuria (PKU)

AU - Surendran, Sankar

AU - Matalon, Dena

AU - Tyring, Stephen K.

AU - Rady, Peter L.

AU - Velagaleti, Gopalrao V

AU - Matalon, Reuben

PY - 2005/7/15

Y1 - 2005/7/15

N2 - Phenylketonuria (PKU) is an inborn error of amino acid metabolism. Phenylalanine hydroxylase (PAH) mutations resulting reduced enzyme levels lead to accumulation of phenylalanine (Phe) in brain, if Phe diet is not restricted. Patients with PKU show neurophysiological abnormalities including demyelination and cognitive defect. How PAH defect causes events seen in PKU is not obvious. Therefore, expression analysis was performed in the brain of a mouse model for PKU. Microarray expression profile of the brain showed lower expression of myocilin (Myoc) in the PKU mouse. Reduced expression of Myoc was further confirmed by one-step real-time RT-PCR. Western blotting analysis of the brain using equal quantities of protein showed a thin band in PKU compared to a prominent band in the wild type brain. In addition, expression of genes associated with transcription was found to be altered in the PKU mouse brain as observed by microarray analysis. These data suggest that PAH defect alters other genes expression likely to contribute neurophysiological abnormalities seen in the mouse, if documented also in patients with PKU.

AB - Phenylketonuria (PKU) is an inborn error of amino acid metabolism. Phenylalanine hydroxylase (PAH) mutations resulting reduced enzyme levels lead to accumulation of phenylalanine (Phe) in brain, if Phe diet is not restricted. Patients with PKU show neurophysiological abnormalities including demyelination and cognitive defect. How PAH defect causes events seen in PKU is not obvious. Therefore, expression analysis was performed in the brain of a mouse model for PKU. Microarray expression profile of the brain showed lower expression of myocilin (Myoc) in the PKU mouse. Reduced expression of Myoc was further confirmed by one-step real-time RT-PCR. Western blotting analysis of the brain using equal quantities of protein showed a thin band in PKU compared to a prominent band in the wild type brain. In addition, expression of genes associated with transcription was found to be altered in the PKU mouse brain as observed by microarray analysis. These data suggest that PAH defect alters other genes expression likely to contribute neurophysiological abnormalities seen in the mouse, if documented also in patients with PKU.

KW - BTBR-PAH

KW - Myoc

KW - Myocilin

KW - Phenylalanine hydroxylase

KW - Phenylketonuria (PKU)

UR - http://www.scopus.com/inward/record.url?scp=19544376846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544376846&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2005.03.030

DO - 10.1016/j.neulet.2005.03.030

M3 - Article

C2 - 15925112

AN - SCOPUS:19544376846

VL - 382

SP - 323

EP - 326

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -